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1. Introduction 
Vascular smooth muscle cells (SMCs) exhibit a wide range of different phenotypes at 
different stages of development (Owens, 1995; Owens et al., 2004; Yoshida & Owens, 2005). 
Even in mature animals, SMCs retain the capability to change their phenotype in response to 
multiple local environmental cues. The plasticity of SMCs enables them to play a critical role 
in physiological processes in the vasculature, as well as the pathogenesis of numerous 
vascular diseases including atherosclerosis, re-stenosis after percutaneous coronary 
intervention, aortic aneurysm, and hypertension. Thus, it is important to understand the 
precise mechanisms whereby SMCs exhibit different phenotypes under distinct conditions. 
Because one of the most remarkable differences among SMC subtypes is the difference in 
expression levels of SMC-specific/-selective genes, elucidation of the molecular mechanisms 
controlling SMC differentiation marker gene expression may shed light on this issue.  
Most of SMC differentiation marker genes characterized to date, including smooth muscle 
(SM) α-actin (Mack & Owens, 1999), SM-myosin heavy chain (SM-MHC) (Madsen et al., 1998), 
SM22α (Li et al., 1996), and h1-calponin (Miano et al., 2000), have multiple highly conserved 
CC(A/T-rich)6GG (CArG) elements in their promoter-enhancer regions. Results of studies in 
vivo have shown that expression of these genes is dependent on the presence of CArG 
elements (Li et al., 1997; Mack & Owens, 1999; Manabe & Owens, 2001a). For example, 
expression of the SM α-actin gene requires a promoter-enhancer region from -2.6 kb to +2.8 
kb to recapitulate the expression patterns of the endogenous gene, and mutation of any one 
of three conserved CArG elements within the regions abolishes the expression (Mack & 
Owens, 1999). Likewise, SMC-specific expression of the SM-MHC gene requires 4.2 kb of the 
5’-flanking region, the entire first exon, and 11.5 kb of the first intronic sequence, and 
mutation of CArG elements in the 5’-flanking region abolishes the expression (Manabe & 
Owens, 2001a). These results indicate the critical roles of CArG elements in the regulation of 
SMC differentiation marker gene expression. Currently, it is reported that over 60 of SMC-
specific/-selective genes possess CArG elements in the promoter-enhancer regions by in-
silico analysis (Miano, 2003), although it is not fully determined how many CArG elements 
of them are functional.  
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The binding factor for CArG elements is the ubiquitously expressed transcription factor, 
serum response factor (SRF) (Norman et al., 1988). Knockout of the SRF gene in mice 
resulted in early embryonic lethality due to abnormal gastrulation and loss in key 
mesodermal markers (Arsenian et al., 1998), precluding the evaluation of requirement of 
SRF for SMC differentiation. Instead, conditional knockout of the SRF gene in the heart and 
SMCs exhibited the attenuation in cardiac trabeculation and the compact layer expansion, as 
well as decreases in SMC-specific/-selective genes including SM α-actin in aortic SMCs 
(Miano et al., 2004). Moreover, SRF has been shown to be required for differentiation of 
SMCs in an in vitro model of coronary SMC differentiation (Landerholm et al., 1999). Indeed, 
over-expression of dominant-negative forms of SRF inhibited the induction of SMC 
differentiation marker genes including SM22α, h1-calponin, and SM α-actin in proepicardial 
cells excised from quail embryos. As such, the preceding studies provide evidence 
indicating that the CArG-SRF complex plays an important role in the regulation of SMC 
differentiation marker gene expression. However, SRF was first cloned as a binding factor 
for the core sequences of serum response element (SRE) in the c-fos gene (Norman et al., 
1988). Because the c-fos gene is known as one of the growth factor-inducible genes, major 
unresolved issues in the field are to identify the mechanisms whereby: (1) the CArG-SRF 
complex can simultaneously contribute to two disparate processes: induction of SMC 
differentiation marker gene expression versus activation of growth-regulated genes; and (2) 
the ubiquitously expressed SRF can contribute to SMC-specific/-selective expression of 
target genes.  
To date, a number of factors have been reported to interact with SRF. Several recent studies 
suggest that these interactions are responsible for multiple actions of SRF. Therefore, this 
review article will summarize recent progress in our understanding of the transcriptional 
mechanisms involved in controlling expression of SMC differentiation marker genes by 
focusing on SRF and its interacting factors.  
2. Myocardin is a potent co-factor of SRF for SMC differentiation marker gene 
expression  
One of the major breakthroughs in the SMC field was the discovery of myocardin (Wang et 
al., 2001). Myocardin was cloned as a co-factor of SRF by a bioinformatics-based screen and 
found to be exclusively expressed in SMCs and cardiomyocytes (Chen et al., 2002; Du et al., 
2003; Wang et al., 2001; Yoshida et al., 2003). It has two isoforms, and smooth muscle-
enriched isoform consists of 856 amino acids (Creemers et al., 2006). Myocardin has several 
domains including three RPEL domains, a basic domain, a glutamine-rich domain, a SAP 
(Scaffold attachment factors A and B, Acinus, Protein inhibitor of activated STAT) domain, 
and a leucine zipper-like domain. It has been shown that leucine zipper-like domain is 
required for homodimerization of myocardin (Figure 1) (Wang et al., 2003), but the function 
of the other domains is not well understood. Transcriptional activation domain, TAD, is 
localized at the carboxy-terminal region, and deletion mutants that lack TAD behaved as 
dominant-negative forms (Wang et al., 2001; Yoshida et al., 2003). Over-expression of 
myocardin potently induces transcription of virtually all CArG-dependent SMC 
differentiation marker genes, including SM α-actin, SM-MHC, SM22α, h1-calponin, and 
myosin light chain kinase (MLCK) (Chen et al., 2002; Du et al., 2003; Wang et al., 2001; Wang et 
al., 2003; Yoshida et al., 2003). Mutation of CArG elements in the SMC promoters abolished 
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the responsiveness to myocardin, suggesting that myocardin activates the transcription in a 
CArG-dependent manner. However, myocardin showed no DNA binding activity, but 
showed interaction with SRF. In addition, myocardin failed to activate the transcription of 
CArG-dependent genes in the absence of SRF (Du et al., 2003), demonstrating that 
myocardin is a co-activator of SRF. Over-expression of myocardin also induced the 
endogenous expression of SMC differentiation marker genes in cultured SMCs and non-
SMCs, including 3T3 fibroblasts, L6 myoblasts, 3T3-L1 preadipocytes, COS cells, and 
undifferentiated embryonic stem cells (Chen et al., 2002; Du et al., 2003; Du et al., 2004; 
Wang et al., 2001; Wang et al., 2003; Yoshida et al., 2003; Yoshida et al., 2004b). However, 
forced expression of myocardin in non-SMCs was not sufficient to induce the full SMC 
differentiation program, because some SMC-enriched genes, which do not contain CArG 
elements in their promoter-enhancer region, were not induced (Yoshida et al., 2004b). 
Nevertheless, it was sufficient to establish a SMC-like contractile phenotype (Long et al., 
2008). Either dominant-negative forms of myocardin or siRNA-induced suppression of 
myocardin decreased the transcription of SMC differentiation marker genes in cultured 
SMCs (Du et al., 2003; Wang et al., 2003; Yoshida et al., 2003). In addition, myocardin-
deficient mice exhibited no vascular SMC differentiation and died by embryonic day 10.5 (Li 
et al., 2003), although this may have been secondary to the defect in the extra-embryonic 
circulation. Moreover, mice lacking the myocardin gene in neural crest-derived cells died 
prior to postnatal day 3 from patent ductus arteriosus, and neural crest-derived SMCs in 
these mice exhibited a cell-autonomous block in expression of SMC differentiation marker 
genes (Huang et al., 2008). Taken together, the preceding results provide compelling 
evidence that myocardin plays a key role in the regulation of expression of SMC 
differentiation marker genes.  
 
Fig. 1. Myocardin potently induces the transcription of CArG-element containing SMC 
differentiation marker genes. Myocardin preferentially activates SMC differentiation marker 
genes which contain multiple CArG elements in their promoter-enhancer regions. 
Homodimerization of myocardin through the leucine zipper-like domain efficiently 
activates the transcription. In contrast, myocardin does not induce the transcription of the 
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2.1 Transcriptional mechanism for myocardin-dependent SMC differentiation marker 
genes 
Although myocardin is a powerful transcriptional co-activator of SRF, there are still some 
questions for the mechanisms whereby myocardin induces SMC differentiation marker 
genes. One of these questions is: “what cis-elements and transcriptional co-activators other 
than SRF are required for the function of myocardin?”  Initial studies (Wang et al., 2001) 
suggested that myocardin activated the transcription through the formation of complex with 
SRF and multiple CArG elements, based on the findings that: (1) the single CArG-containing 
c-fos gene had no responsiveness to myocardin; and (2) myocardin could activate an 
artificial promoter consisting of 4x c-fos SREs coupled to the basal promoter. Such a “2-
CArG” model, in which multiple CArG elements are required for myocardin-induced 
transactivation, is strengthened by the results showing that homodimerization of myocardin 
extraordinary augmented the transcriptional activity of SMC differentiation marker genes 
(Figure 1) (Wang et al., 2003). However, several SMC-specific genes that only contain single 
CArG element in their promoter, such as the telokin gene and the cysteine-rich protein-1 (CRP-
1) gene, have also been shown to be activated by myocardin (Wang et al., 2003; Yoshida et 
al., 2004b). These results raised a question as to how myocardin distinguishes these single 
CArG-containing SMC differentiation marker genes from the c-fos gene. One hypothesis is 
that the presence of a ternary complex factor (TCF)-binding site in the c-fos promoter 
regulates the binding of myocardin to SRF. In support of this, it has been shown that one of 
the TCFs, Elk-1, could compete for SRF binding with myocardin on the SMC promoters 
(Wang et al., 2004; Yoshida et al., 2007; Zhou et al., 2005). Such a possibility will be discussed 
in detail in a later section.  
An additional possibility is that degeneracy within CArG elements, i.e. conserved base pair 
substitutions that reduce SRF binding affinity, contributes to the promoter selectivity of 
myocardin. Consistent with this idea, the majority of SMC differentiation marker genes 
including SM α-actin and SM-MHC have degenerate CArG elements in their promoter-
enhancer regions (Miano, 2003). For example, both of CArG elements located within 5’-
flanking region of the SM α-actin gene contain a single G or C substitution within their A/T-
rich cores that is 100% conserved between species as divergent as humans and chickens 
(Shimizu et al., 1995). Results of our previous studies showed that substitution of SM α-actin 
5’ CArGs with the c-fos consensus CArGs significantly attenuated injury-induced 
downregulation of SM α-actin expression (Hendrix et al., 2005). In addition, of interest, over-
expression of myocardin selectively enhanced SRF binding to degenerate SM α-actin CArG 
elements compared to c-fos consensus CArG element in SMCs, as determined by 
quantitative chromatin immunoprecipitation assays. These results raise a possibility that the 
degeneracy in the CArG elements is one of the determinants of promoter selectivity of 
myocardin. However, it should be noted that there is a difference not only in the sequence 
context of CArG elements, but also in the number of CArG elements between the SM α-actin 
gene versus the c-fos gene. Moreover, there is no G or C substitution in the CArG elements 
of several SMC differentiation marker genes including the SM22α, telokin, and CRP-1 genes 
(Miano, 2003), although previous studies showed that the binding affinity of SRF to SM22α 
CArG-near element was lower than that to the c-fos CArG element by electromobility shift 
assays (EMSA) (Chang et al., 2001). It is interesting to determine whether CArG elements in 
the telokin gene and the CRP-1 genes also exhibit lower binding affinity to SRF than the c-fos 
www.intechopen.com
Molecular Control of Smooth Muscle Cell Differentiation  
Marker Genes by Serum Response Factor and Its Interacting Proteins 
 
27 
consensus CArG element. If this is the case, it is likely that reduced SRF binding to CArG 
elements, which does not necessarily have G or C substitutions, is one of the mechanisms for 
target gene selectivity of myocardin. If this is not the case, it is still possible that the 
degeneracy in CArG elements may explain a part of the promoter selectivity of myocardin, 
but this mechanism cannot be applicable to all of the SMC differentiation marker genes.  
Regarding the mechanism of myocardin-induced transcription of SMC differentiation 
marker genes, the physical interaction of myocardin with histone acetyltransferase, p300, 
and class II histone deacetylases, HDAC4 and HDAC5, has been reported (Cao et al., 2005). 
Indeed, results showed that over-expression of myocardin induced histone H3 acetylation in 
the vicinity of CArG elements at the SM α-actin and SM22α promoters in 10T1/2 cells (Cao 
et al., 2005). In addition, they showed that p300 augmented the stimulatory effect of 
myocardin on the transcription of the SM22α gene, whereas either HDAC4 or HDAC5 
repressed the effect of myocardin by co-transfection/reporter assays. Moreover, they 
demonstrated that p300 and HDACs, respectively, bound to distinct domains of myocardin 
simultaneously, suggesting that the balance between p300 and HDACs is likely to be one of 
the determinants of the transcriptional activity of myocardin.  
These results are of significant interest in that they provided evidence that transcription of 
SMC differentiation marker genes is regulated by the recruitment of chromatin modifying 
enzymes by myocardin. Previous studies showed that SMC differentiation was associated 
with increased binding of SRF and hyperacetylation of histones H3 and H4 at CArG-
containing regions of the SM α-actin and SM-MHC genes in A404 SMC precursor cells 
(Manabe & Owens, 2001b). In addition, we showed that over-expression of myocardin 
selectively enhanced SRF binding to CArG-containing region of the SM α-actin gene, but not 
to that of the c-fos gene in the context of intact chromatin in SMCs (Hendrix et al., 2005). 
Results of studies by another group (Qiu & Li, 2002) also showed that HDACs reduced the 
transcriptional activity of the SM22α gene in a CArG-element dependent manner. These 
findings are consistent with the results showing the association of myocardin with p300 or 
HDACs (Cao et al., 2005). However, it remains unknown how the association between 
myocardin and p300 or HDACs regulates the accessibility of SRF to CArG elements, as has 
been observed during the induction of SMC differentiation in A404 cells (Manabe & Owens, 
2001b). It is possible that particular histone modifications by the myocardin-p300 complex 
enable SRF to bind to CArG-elements within the SMC promoters. It is also possible that the 
association between myocardin and chromatin modifying enzymes including p300 may 
alter the binding affinity of myocardin to SRF. Because regulation of SMC differentiation 
marker genes by platelet-derived growth factor-BB (PDGF-BB) or oxidized phospholipids 
has been shown to be accompanied by the recruitment of HDACs and thereby changes in 
acetylation levels at the SMC promoters (Yoshida et al., 2007, 2008a), it is interesting to 
determine if these changes are caused by the modulation of association between myocardin 
and these chromatin modifying enzymes.  
2.2 Role of the myocardin-related family in SMC differentiation   
Two factors were identified as members of the myocardin-related transcription factors: 
MKL1 (also referred to as MAL, BSAC, and MRTF-A) (Cen et al., 2003; Miralles et al., 2003; 
Sasazuki et al., 2002; Wang et al., 2002) and MKL2 (also referred to as MRTF-B) (Selvaraj & 
Prywes, 2003; Wang et al., 2002). It has been shown that expression of MKL1 mRNA is 
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ubiquitous, whereas expression of MKL2 mRNA is restricted to several tissues including the 
brain and the heart (Cen et al., 2003; Selvaraj & Prywes, 2003; Wang et al., 2002). Co-
transfection studies revealed that both MKL1 and MKL2 were capable of inducing the 
transcription of multiple CArG-containing promoters including atrial natriuretic factor (ANF), 
SM22α, SM α-actin, and cardiac α-actin. A truncated MKL2 protein that lacks both amino-
terminal region and carboxy-terminal region (MKL2∆N∆C700) behaved as a dominant-
negative manner for both MKL1 and MKL2, and over-expression of MKL2∆N∆C700 inhibited 
skeletal muscle differentiation in C2C12 skeletal myoblasts (Selvaraj & Prywes, 2003). In 
addition, MKL1 strongly induced SMC differentiation marker gene expression in 
undifferentiated embryonic stem cells, even in the absence of myocardin (Du et al., 2004). 
Moreover, a truncated form of MKL1, which behaved as a dominant-negative form of MKL1 
and myocardin, inhibited MKL1-induced transcription of the SM22α gene (Du et al., 2004). 
Taken together, MKL factors appear to be important regulators of SMC differentiation marker 
gene expression as well as myocardin, and they appear to exhibit the redundant function with 
myocardin as SRF co-factors. However, the precise roles of MKL factors in SMC differentiation 
marker gene expression in SMCs are still unclear, because most of these studies analyzing the 
function of MKL factors have been performed by over-expression experiments. Regarding this 
point, there are several interesting studies as described below. First, MKL1 knockout mice 
were viable, but were unable to effectively nurse their offspring due to a failure in 
maintenance of the differentiated state of mammary myoepithelial cells during lactation (Li et 
al., 2006; Sun et al., 2006). Second, conditional knockout of the MKL2 gene in neural crest-
derived cells exhibited a spectrum of cardiovascular defects including abnormal patterning of 
the branchial arch arteries (Li et al., 2005; Oh et al., 2005). The abnormalities in MKL2 knockout 
mice were accompanied by a decrease in SM α-actin expression in SMCs within the branchial 
arch arteries. Based on the results of these studies, MKL1 is unlikely to play an important role 
in expression of SMC differentiation marker genes in vivo. In addition, role of MKL2 for SMC 
differentiation in SMCs derived from other origins is still unknown. A biggest issue is how 
broadly expressed MKL factors regulate SMC-specific/-selective CArG-dependent genes. 
Recently, several studies suggest the importance of intracellular localization of MKL factors in 
SMCs and non-SMCs (Hinson et al., 2007; Nakamura et al., 2010; Yoshida et al., 2007). Further 
studies are required to address this issue.  
In summary, it is clear that myocardin plays a critical role in SMC differentiation in concert 
with the CArG-SRF complex. However, myocardin is not a SMC-specific gene in that it is 
also expressed in cardiomyocytes, suggesting that myocardin alone is not enough to 
coordinate expression of SMC differentiation marker genes. It is highly likely that 
cooperative interaction of the SRF-myocardin complex with other transcription factors is 
necessary for expression of SMC differentiation marker genes in SMCs. Further studies are 
needed to clarify these combinatorial mechanisms.  
3. Ternary complex factors exhibit dual roles in the transcription of SRF-
dependent CArG-Containing genes 
TCFs are a subfamily of the Ets domain transcription factors (Buchwalter et al., 2004). TCF 
was first described as 62 kD nuclear fractions (p62) that form a ternary complex with SRF on 
the c-fos SRE (Shaw et al., 1989). Three members, Elk-1, Sap-1/Elk-4, and Net/Sap-2/Elk-3, 
have been identified as TCFs. Previous studies demonstrated that TCFs are present on SREs 
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of the c-fos gene with SRF dimers both before and after growth factor stimulation, and that 
after the stimulation with growth factors, TCFs are phosphorylated and activate 
transcription of the c-fos gene (Buchwalter et al., 2004).  
Although it has been believed, for a long time, that most of SMC differentiation marker 
genes lack the TCF-binding site in their promoter regions (Miano 2003), results of recent 
studies by multiple laboratories including our own (Wang et al., 2004; Yoshida et al., 2007; 
Zhou et al., 2005) suggest the involvement of Elk-1 in the regulation of SMC differentiation 
marker genes. They presented evidence that repression of SMC differentiation marker genes 
including SM α-actin and SM22α by PDGF-BB was due to the displacement of myocardin 
from SRF by phosphorylated Elk-1 in cultured SMCs (Figure 2). Indeed, they showed that 
treatment with PDGF-BB induced phosphorylation of Elk-1 through the activation of the 
MEK1/2-Erk1/2 pathway and increased the association between Elk-1 and SRF, whereas 
the association between myocardin and SRF was decreased at the same time. By extensively 
mapping the domain of myocardin and Elk-1, they found that both factors have a 
structurally related SRF-binding motif and thereby compete for the common docking region 
of SRF. These results are very interesting in that phosphorylation of Elk-1 simultaneously 
exhibits the dual roles in the regulation of CArG-dependent genes: transcriptional activation 
of the c-fos gene versus transcriptional repression of SMC differentiation marker genes.  
 
Fig. 2. Phosphorylation of Elk-1 competes for SRF binding with myocardin. The myocardin-
SRF-CArG complex activates the transcription of SMC differentiation marker genes in the 
absence of growth factors as shown in Fig. 1. Activation of the Erk1/2 pathway by growth 
factors such as PDGF-BB induces phosphorylation of Elk-1. Phosphorylated Elk-1 displaces 
myocardin from SRF and binds to SRF, thereby suppressing the transcription of SMC 
differentiation marker genes. It has been reported that phosphorylated Elk-1 is able to bind 
to the TCF-binding site within the SM22α promoter (Wang et al., 2004), although the TCF-
binding site is not present within the promoter region of most SMC differentiation marker 
genes.  
However, the mechanisms responsible for these dual effects have not been clearly 
understood yet. That is, although the binding of Elk-1 on the putative TCF-binding site (5’-
TTCCCG-3’) adjacent to the CArG-far element at the SM22α promoter was detected by 
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EMSA and chromatin immunoprecipitation assays (Wang et al., 2004), this sequence is not 
the consensus binding site for Elk-1 (Treisman et al., 1992). By using “the site selection 
method” to purify DNA capable of forming ternary complexes from a pool of randomized 
oligonucleotides, the consensus binding motif for Elk-1 and Sap-1 was determined as 5’-
(C/A)(C/A)GGA(A/T)-3’ previously (Treisman et al., 1992). The putative TCF-binding site 
within the SM22α gene (sense: 5’-TTCCCG-3’ and antisense: 5’-CGGGAA-3’) does not 
match this sequence completely. In addition, although over-expression of Elk-1 
downregulated the SM22α promoter-luciferase activity through the competition with 
myocardin, this competition was still observed when the mutational SM22α-luciferase 
construct, in which the putative TCF-binding site was abolished, was used. Furthermore, 
there is no putative Elk-1 binding site near the CArG elements within the SM α-actin 
promoter (Mack & Owens, 1999). Because chromatin immunoprecipitation assays can detect 
not only the direct binding of protein to DNA sequence, but also the binding of protein to 
protein, it is highly possible that the attachment of Elk-1 to the TCF-binding site may not be 
absolutely required for the competition with myocardin for SRF binding. Nevertheless, the 
SM22α promoter with a mutation in the TCF-binding site has been reported to direct ectopic 
transcription in the heart in a later embryonic stage, as compared with the wild-type SM22α 
promoter in vivo (Wang et al., 2004). Further studies are needed to determine if these 
findings are applicable to multiple SMC differentiation marker genes.  
It is also of interest to determine whether the activation of Elk-1 can recruit histone 
deacetylases to the promoter regions of SMC differentiation marker genes. Elk-1 contains 
two transcriptional repression domains, an N-terminal transcriptional repression domain 
and an R motif located in the C-terminal transcriptional activation domain (Buchwalter et 
al., 2004). It has been shown that HDAC1 and HDAC2 were recruited to the N-terminal 
transcriptional repression domain of Elk-1 on the c-fos promoter followed by the activation 
of the MEK1/2-Erk-1/2 pathway, and this recruitment kinetically correlated with the 
shutoff of the c-fos gene expression after growth factor stimulation (Yang et al., 2001; Yang & 
Sharrocks, 2004). We previously showed that repression of SMC differentiation marker 
genes after stimulation with PDGF-BB was accompanied by the recruitment of multiple 
HDACs, HDAC2, HDAC4, and HDAC5 in cultured SMCs (Yoshida et al., 2007). It is 
possible that the association between Elk-1 and these HDACs on the SMC promoters is one 
of the mechanisms for repression of SMC differentiation marker gene expression. Moreover, 
it was reported that SUMO modification of the R motif in Elk-1 could antagonize the 
MEK1/2-Erk1/2 pathway and repress the transcription of the c-fos gene (Yang et al., 2003). 
Thus, it is also possible that PDGF-BB can induce sumoylation of Elk-1 and exhibit the 
repressive effects on SMC differentiation marker genes.  
In summary, the preceding results indicate that Elk-1 plays dual roles in the transcription of 
CArG-dependent genes as both an activator and a repressor. However, there are still some 
questions as discussed above. Clearly, one of the most fascinating questions is to determine 
if knockdown of Elk-1 abolishes PDGF-BB-induced repression of SMC differentiation 
marker genes both in vivo and in vitro.  
4. Multiple homeodomain proteins regulate SMC differentiation   
Homeodomain proteins are a family of transcription factors with a highly conserved DNA-
binding domain that regulate cell proliferation, differentiation, and migration in many cell 
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types during embryogenesis (Gorski & Walsh, 2003). This family is comprised of over 160 
genes, and it has been reported that several homeodomain proteins are able to regulate 
differentiation of SMCs by interacting with the CArG-SRF complex.  
One of these factors is Prx-1 (Paired-related homeobox gene-1), which is also known as MHox 
and Phox (Cserjesi et al., 1992; Grueneberg et al., 1992). Expression of Prx-1 is completely 
restricted to mesodermally derived cell types during embryogenesis and to cell lines of 
mesodermal origin including cultured aortic SMCs (Blank et al., 1995; Cserjesi et al., 1992). 
Previous studies from our laboratory and others showed that Prx-1 was capable of inducing 
the transcription of the CArG-SRF dependent genes (Grueneberg et al., 1992; Hautmann et al., 
1997; Yoshida et al., 2004a). Indeed, we found that angiotensin II increased expression of 
multiple SMC differentiation marker genes including SM α-actin, as well as Prx-1 expression in 
cultured SMCs (Hautmann et al., 1997; Turla et al., 1991; Yoshida et al., 2004a). Of major 
interest, we provided evidence that siRNA-induced suppression of Prx-1 dramatically reduced 
both basal and angiotensin II-induced transcription of the SM α-actin gene (Yoshida et al., 
2004a). In addition, Prx-1 increased the SRF binding to degenerate CArG B element within the 
SM α-actin gene by EMSA (Hautmann et al., 1997). Similarly, Prx-1 enhanced the binding of 
SRF to c-fos CArG element by EMSA (Grueneberg et al., 1992). However, the formation of a 
stable higher order complex comprised of Prx-1, SRF, and CArG element was not detected by 
EMSA. Rather, Prx-1 enhanced both the rate of association and the rate of dissociation between 
SRF and CArG element, thereby increasing the rate of exchange of SRF on the CArG element. 
Although further studies are required to clarify these mechanisms in detail, results thus far 
suggest that Prx-1 plays a key role in the transcription of CArG-dependent genes through 
regulating the binding of SRF to CArG elements.  
Although the preceding results suggest that Prx-1 is involved in the regulation of SMC 
differentiation marker gene expression (Hautmann et al., 1997; Yoshida et al., 2004a), it also 
plays a role in proliferation of SMCs. Prx-1 expression was induced during the development 
of pulmonary vascular disease in adult rats, and Prx-1 enhanced the proliferation rate of 
cultured rat A10 SMCs via the induction of tenascin-C expression (Jones et al., 2001). Taken 
together, results suggest that Prx-1 plays multiple roles in the regulation of differentiation 
status and the regulation of proliferation status in SMCs. This is consistent with the idea that 
differentiation and proliferation are not necessarily mutually exclusive processes (Owens & 
Thompson, 1986; Owens et al., 2004). However, it remains unknown whether Prx-1 exhibits 
these two roles simultaneously or Prx-1 exhibits distinct roles in a developmental stage-
specific manner. Of interest, Prx-1 knockout mice have been made and shown to exhibit 
major defects in skeletogenesis and die soon after birth (Martin et al., 1995). Mice null for 
both Prx-1 and its homologue, Prx-2, showed a vascular abnormality with an abnormal 
positioning and awkward curvature of the aortic arch and a misdirected and elongated 
ductus arteriosus (Bergwerff et al., 2000). Moreover, expression of endothelial markers such 
as Flk-1 and VCAM-1 and von Willebrand factor-positive cells were decreased in the lung of 
Prx-1 null newborn mice (Ihida-Stansbury et al., 2004), suggesting that Prx-1 is required for 
lung vascularization in vivo. It will be of interest to directly test the role of Prx-1 in CArG-
dependent SMC differentiation marker gene expression in these mice.  
Another homeodomain protein related to SMC differentiation is Hex. Hex was originally 
isolated from hematopoietic tissues by PCR using degenerate oligonucleotide primers 
corresponding to the conserved homeodomain sequences and has been shown to play an 
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important role in inducing differentiation of vascular endothelial cells (Thomas et al., 1998). 
In SMCs, Hex protein expression was induced in the neointima after balloon injury of rat 
aorta, while it was undetectable in normal aorta (Sekiguchi et al., 2001). The expression 
pattern of Hex was similar to that of SMemb/NMHC-B, a marker of phenotypically 
modulated SMCs. Hex induced the transcription of the SMemb promoter, and cAMP-
responsive element (CRE) located at -481 bp within the promoter was critical for Hex 
responsiveness. However, Hex failed to bind to CRE directly, thus the precise mechanisms 
whereby Hex activated the SMemb promoter are still unclear. Of interest, subsequent studies 
showed that Hex also induced expression of a subset of SMC differentiation marker genes 
including SM α-actin and SM22α, but not SM-MHC and h1-calponin (Oyama et al., 2004). 
Hex induced the transcription of the SM22α gene in a CArG-dependent manner, and it 
enhanced the binding of SRF to CArG-near element within the SM22α promoter, as 
determined by EMSA. In addition, immunoprecipitation assays revealed the physical 
association between SRF and Hex. As such, the mechanisms whereby Hex induces SMC 
differentiation marker genes seem to be similar to those of Prx-1. However, results showing 
that Hex simultaneously activated expression of both SMC differentiation marker genes and 
those characteristic of phenotypically modulated SMCs are paradoxical, and further studies 
are clearly needed to precisely define the pathophysiological role of Hex in SMCs.  
Nkx-3.2 is also a homeodomain protein that regulates expression of SMC differentiation 
marker genes (Nishida et al., 2002). It has been demonstrated that a triad of SRF, GATA-6, 
and Nkx-3.2 formed a complex with their corresponding cis-elements and cooperatively 
transactivated SMC differentiation marker genes including α1-integrin, SM22α, and 
caldesmon. Because co-localization of GATA-6, Nkx-3.2, and SRF was exclusively observed in 
SMCs, SMC-specific gene expression does not appear to be the result of any single 
transcription factor that is unique to SMCs, but rather is due to unique combinatorial 
interactions of factors that may be expressed in multiple cell types but only found together 
in SMCs.  
Furthermore, we recently identified Pitx2 as a homeodomain protein which is required for 
the initial induction of SMC differentiation by using a subtraction hybridization screen 
(Shang et al., 2008). Over-expression of Pitx2 induced expression of CArG-dependent SMC 
differentiation marker genes, whereas knockdown of Pitx2 attenuated retinoic acid-induced 
differentiation of SMCs from undifferentiated SMC precursor cells. Furthermore, Pitx2 
knockout mouse embryos exhibited impaired induction of SMC differentiation markers in 
the dorsal aorta and branchial arch arteries. We identified three mechanisms for Pitx2-
induced transcription of SMC differentiation marker genes (Figure 3). First, Pitx2 bound to 
its consensus TAATC(C/T) element in the promoter region of SMC differentiation marker 
genes. Second, Pitx2 physically associated with SRF. Third, Pitx2 mediated exchange of 
HDACs with p300 to increase acetylation levels of histone H4 at the SMC promoters. These 
results provide compelling evidence that Pitx2 plays a critical role in the induction of SMC 
differentiation during the early embryogenesis. Further studies are needed to determine if 
Pitx2 also contributes to the pathogenesis of vascular diseases including atherosclerosis.  
As such, several homeodomain proteins are involved in the regulation of CArG-SRF 
dependent SMC differentiation marker gene expression, and some of the mechanisms 
appear to be mediated by common pathways. Further studies are needed to clarify the 
temporal and spatial roles of each of these homeodomain proteins in SMC differentiation. 
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Fig. 3. Pitx2 transactivates SMC differentiation marker genes through three mechanisms. 
Pitx2 induces expression of SMC differentiation marker genes by: (1) binding to a consensus 
TAATC(C/T) cis-element; (2) interacting with SRF; and (3) mediating exchange of HDACs 
with p300 at the promoter region of SMC differentiation marker genes. These mechanisms 
are important for the initial induction of SMC differentiation during the early embryonic 
development. 
5. A number of factors associate with SRF 
In addition to the factors described above, there are a number of transcription factors known 
to interact with SRF. These factors also play key roles in the control of SMC differentiation 
marker gene expression. In this section, some of these transcription factors will be discussed 
briefly.  
5.1 GATA-6 
GATA proteins are a family of zinc finger transcription factors, and play essential roles in 
development through their interaction with a DNA consensus element, “WGATAR” 
(Molkentin, 2000). Six GATA transcription factors have been identified in vertebrates, and 
GATA-4, GATA-5, and GATA-6 are thought to be involved in the formation of the heart, 
gut, and vessels. During the early murine embryonic development, expression patterns of 
GATA-6 and GATA-4 were similar, with expression being detected in the precardiac 
mesoderm, the embryonic heart tube, and the primitive gut (Morrisey et al., 1996). However, 
during the late development, GATA-6 became the only GATA factor to be expressed in 
vascular SMCs. Knockout of the GATA-6 gene in mice resulted in embryonic lethality 
between embryonic day 6.5 and 7.5, precluding the evaluation of the role of GATA-6 in SMC 
differentiation and maturation (Morrisey et al., 1998).  
As described in a previous section, GATA-6 has shown to interact with SRF and Nkx-3.2 
and to induce SMC differentiation marker gene expression (Morrisey et al., 1998; Nishida et 
al., 2002). GATA-6 expression in SMCs was rapidly downregulated after vascular injury in 
rat carotid arteries, and adenovirus-mediated transfer of GATA-6 to the vessel wall after the 
balloon injury partially inhibited the formation of intimal thickening and reversed the 
downregulation of SMC differentiation marker genes including SM α-actin and SM-MHC 
(Mano et al., 1999). These results suggest the important role of GATA-6 in regulating SMC 
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differentiation. Of interest, results of studies (Yin & Herring, 2005) showed that GATA-6 
increased the transcriptional activity of the SM α-actin and SM-MHC genes, whereas it 
reduced the transcriptional activity of the telokin gene. They found that the GATA-6 binding 
site was located adjacent to CArG element in the telokin promoter and that over-expression 
of GATA-6 interfered the interaction between myocardin and SRF by mammalian two-
hybrid assays. However, it is unclear why GATA-6 has positive and negative effects on 
CArG-dependent SMC differentiation marker genes. It is possible that these opposite effects 
are due to the number of CArG elements or the distance between the GATA-6 binding site 
and the CArG element. Further studies are needed to test these possibilities.  
5.2 Klf4 
Klf4 is a member of Krüppel-like transcriptional factors that have recently received 
increased attention. Previously, Klf4 was identified as a binding factor for the transforming 
growth factor-β1 control element (TCE) found in the promoter region of the SM α-actin and 
SM22α genes, based on a yeast one-hybrid screen (Adam et al., 2000). Klf4 exhibited a 
profound inhibitory effect on expression of SMC differentiation marker genes via a TCE-
dependent and a CArG-SRF-dependent manner (Liu et al., 2003, 2005). For example, 
adenovirus-mediated over-expression of Klf4 repressed endogenous expression of SM α-
actin and SM-MHC genes, as well as expression of myocardin, in cultured SMCs as measured 
by real-time reverse transcription-PCR (Liu et al., 2005). In addition, over-expression of Klf4 
completely abolished myocardin-induced activation of SMC differentiation marker genes. 
Co-immunoprecipitation assays revealed that Klf4 physically interacted with SRF, and 
chromatin immunoprecipitation assays showed that over-expression of Klf4 markedly 
reduced the binding of SRF to CArG elements on the SM α-actin promoter in intact 
chromatin of cultured SMCs (Liu et al., 2005). Moreover, PDGF-BB treatment induced Klf4 
mRNA expression in cultured SMCs, and siRNA-induced suppression of Klf4 partially 
blocked PDGF-BB-induced suppression of SMC differentiation marker genes (Liu et al., 
2005). Of significant interest, we demonstrated that conditional knockout of the Klf4 gene in 
mice exhibited a delay in suppression of SMC differentiation markers, and an enhanced 
neointimal formation following vascular injury (Figure 4) (Yoshida et al., 2008b). 
Additionally, we showed that Klf4, Elk-1, and HDACs cooperatively suppress oxidized 
phospholipid-induced suppression of SMC differentiation marker genes in cultured SMCs 
(Yoshida et al., 2008a). Taken together, these results suggest that Klf4 plays a key role in 
mediating phenotypic switching of SMCs.  
5.3 Cysteine-rich LIM-only proteins, CRP1 and CRP2 
The members of the cysteine-rich LIM-only protein (CRP) family, CRP1 and CRP2, are 
expressed predominantly in SMCs and contain two LIM domains in the structure 
(Henderson et al., 1999; Jain et al., 1996). It is known that the functions of LIM domains are 
to mediate protein-protein interactions, to target proteins to distinct subcellular locations, 
and to mediate assembly of multimeric protein complexes. One of the functions of CRP1 and 
CRP2 is to interact with both the actin crosslinking protein, α-actinin, and the adhesion 
plaque protein, zyxin, and to regulate the stability and structure of adhesion complexes 
(Arber & Caroni, 1996; Schmeichel & Beckerle, 1994). In addition to such a cytoplasmic role,  
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Fig. 4. Conditional knockout of the Klf4 gene in mice accelerates neointimal formation 
following vascular injury. Klf4 is a potent repressor of SMC differentiation marker genes. 
Interestingly, conditional knockout of the Klf4 gene in mice delays downregulation of SMC 
differentiation markers, but also accelerates neointimal formation after vascular injury 
(Yoshida et al., 2008).  
it has been reported that CRP1 and CRP2 are also able to function as transcriptional co-
factors (Chang et al., 2003). Over-expression of three factors, SRF, GATA-6, and CRP1/CRP2 
strongly activated the transcription of SMC differentiation marker genes including SM α-
actin, SM-MHC, SM22α, h1-calponin, and h-caldesmon. The N-terminal LIM domain of 
CRP1/2 interacted with SRF, and that the C-terminal LIM domain of CRP1/2 interacted 
with GATA-6, and that SRF and GATA-6 also interacted each other. These results suggest a 
critical role of CRP1/2 in organizing multiprotein complexes onto the SMC promoters for 
SMC differentiation. However, it is still unclear how CRP1 and CRP2 are translocated from 
the cytoplasm to the nucleus and what signaling pathways control their nuclear localization. 
Moreover, there is a lack of evidence that these factors play a role in control of SMC 
differentiation marker gene expression in vivo in SMCs. Indeed, results of recent studies 
showed that SMC differentiation in CRP1 knockout mice or CRP2 knockout mice appeared 
to be normal, although neointimal formation was altered after vascular injury (Lilly et al., 
2010; Wei et al., 2005). Results raised a question as to the role of CRP1/2 in SMC 
differentiation.  
5.4 PIAS-1 
Results of previous studies showed that over-expression of class I basic Helix-Loop-Helix 
proteins, E2-2, and SRF exhibited a synergistic effect on the transcription of the SM α-actin 
promoter-enhancer in BALBc/3T3 cells (Kumar et al., 2003). However, direct interaction 
between E2-2 and SRF was undetectable by EMSA using the recombinant proteins. We 
isolated PIAS-1 (protein inhibitor of activated STAT-1) as an interacting protein for E2-2 by a 
yeast two-hybrid screen (Kawai-Kowase et al., 2005). We also found that PIAS-1 interacted 
with SRF, suggesting that PIAS-1 works as a bridging molecule between E2-2 and SRF. 
Interestingly, PIAS-1 belongs to a family of E3 ligases which promote SUMO modifications 
of target proteins (Schmidt & Müller, 2002). Indeed, recent studies showed that transcription 
factors involved in SMC differentiation, such as myocardin and Klf4, were sumoylation 
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targets of PIAS-1. Myocardin sumoylation by PIAS-1 transactivated cardiogenic genes in 
10T1/2 fibroblasts (Wang et al., 2007), whereas sumoylation of Klf4 by PIAS-1 promoted 
transforming growth factor-β induced activation of SM α-actin expression in SMCs (Kawai-
Kowase et al., 2009). Further studies are needed to determine effects of PIAS-1 knockout on 
SMC differentiation as well as phenotypic switching of SMCs.  
6. Conclusion and perspectives  
As discussed above, it is clear that the CArG-SRF complex plays a central role in the 
regulation of SMC differentiation marker gene expression. However, it is also clear that 
expression of SMC differentiation marker genes is not controlled by the CArG-SRF complex 
alone, nor by any single transcription factor that is expressed exclusively in SMCs. Rather, 
SMC-selective gene expression appears to be mediated by complex combinatorial 
interactions of multiple transcription factors and co-factors, including some that are 
ubiquitously expressed like SRF and PIAS-1, as well as others that are selective for SMCs 
like myocardin, Prx-1, CRP-1/2, and GATA-6. In addition to the transcription factors 
described above, several novel factors, including Fhl2 (Philippar et al., 2004), HERP1 (Doi et 
al., 2005) and lupaxin (Sundberg-Smith et al., 2008), have also been identified as factors 
interacting with SRF.  
However, our knowledge is immature regarding the overall connection among multiple 
transcription factors and co-factors that can modify the activity of SRF. Most of studies 
analyzing the protein-protein interaction thus far have been focused on the relationship 
among two or three proteins. However, a number of factors should be coordinately 
regulated and interacted by a single environmental cue. It is of interest to determine 
whether all of SRF-interacting factors are simultaneously required for SMC differentiation 
marker gene expression or these factors independently contribute to SMC differentiation 
marker gene expression in time- and position-specific manner. Thus, in the long term, future 
studies in the SMC field are needed not only to screen out other key transcription factors, 
but also to map out the connection networks of these factors.  
During the past decade, there is a tremendous progress in our understanding of the roles 
of chromatin modifying enzymes and chromatin structure in gene transcription in all cell 
types. Accumulating evidence indicates that the N-terminal tails of histones are the target 
of numerous modifications, including acetylation, methylation, phosphorylation, 
ubiqutination, and ADP ribosylation, and that these modifications control gene 
transcription (Fischle et al., 2003). However, this issue in the SMC field is obviously in its 
infancy. Thus far, only several transcription factors have been reported to be involved in 
chromatin remodeling. Clearly, more detailed studies are required to determine the 
mechanisms whereby SRF and its interacting factors coordinately contribute to chromatin 
remodeling.  
Finally, although much progress has been made in our understanding of the role of 
transcription factors in the control of SMC differentiation marker gene expression, some of 
these studies are performed only in cultured SMCs or SM-like systems. Studies of these 
factors in vivo will provide more compelling information to enhance our knowledge about 
SMC differentiation and development.  
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